Phase I Clinical Study of QLS-1304 in the Treatment of Patients With Advanced Malignant Tumors

Clinical trial NCT06823609 · RECRUITING

Trial details

NCT number: NCT06823609
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Tumor

Start date: 2025-03-06
Primary completion: 2026-11-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.